Paper9637488
Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity.
Matsumoto G and 4 others. J Immunol, 1998. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. Papers, record 9637488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9637488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Adhesion | Major topic |
| Hyaluronan Receptors | Major topic |
| Killer Cells, Lymphokine-Activated | Major topic |
| Lymphocyte Function-Associated Antigen-1 | Major topic |
| Animals | |
| Cell Differentiation | |
| Cytotoxicity, Immunologic | |
| Fas Ligand Protein | |
| Hyaluronic Acid | |
| Interleukin-2 | |
| Ligands | |
| Membrane Glycoproteins | |
| Mice | |
| Perforin | |
| Pore Forming Cytotoxic Proteins | |
| Spleen | |
| Tumor Cells, Cultured | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40312550 | Mechanoregulation of lymphocyte cytotoxicity. | Nat Rev Immunol | 2025 | https://conductscience.org/library/papers/40312550 | PubMed |
| 40277910 | Softness or Stiffness What Contributes to Cancer and Cancer Metastasis? | Cells | 2025 | https://conductscience.org/library/papers/40277910 | PubMed |
| 37078002 | Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia. | Front Oncol | 2022 | https://conductscience.org/library/papers/37078002 | PubMed |
| 36936902 | The role of hyaluronan in renal cell carcinoma. | Front Immunol | 2023 | https://conductscience.org/library/papers/36936902 | PubMed |
| 36544762 | IRF2 is required for development and functional maturation of human NK cells. | Front Immunol | 2022 | https://conductscience.org/library/papers/36544762 | PubMed |
| 35680882 | Mechanically active integrins target lytic secretion at the immune synapse to facilitate cellular cytotoxicity. | Nat Commun | 2022 | https://conductscience.org/library/papers/35680882 | PubMed |
| 34948293 | Cathepsin X Activity Does Not Affect NK-Target Cell Synapse but Is Rather Distributed to Cytotoxic Granules. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948293 | PubMed |
| 33777044 | Natural Killer Cell Integrins and Their Functions in Tissue Residency. | Front Immunol | 2021 | https://conductscience.org/library/papers/33777044 | PubMed |
| 30333226 | A dynamic transcriptomic atlas of cytokine-induced killer cells. | J Biol Chem | 2018 | https://conductscience.org/library/papers/30333226 | PubMed |
| 26552706 | DNAM-1 controls NK cell activation via an ITT-like motif. | J Exp Med | 2015 | https://conductscience.org/library/papers/26552706 | PubMed |
| 25324695 | Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis. | Int J Biomed Sci | 2014 | https://conductscience.org/library/papers/25324695 | PubMed |
| 24795719 | Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control. | Front Immunol | 2014 | https://conductscience.org/library/papers/24795719 | PubMed |
| 23948654 | Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b. | Circ Res | 2013 | https://conductscience.org/library/papers/23948654 | PubMed |
| 23179049 | Cellular immune mechanisms in myocarditis. | Herz | 2012 | https://conductscience.org/library/papers/23179049 | PubMed |
| 22566907 | Regulation of Antigen-Experienced T Cells: Lessons from the Quintessential Memory Marker CD44. | Front Immunol | 2012 | https://conductscience.org/library/papers/22566907 | PubMed |
| 20818413 | Current perspectives of natural killer cell education by MHC class I molecules. | Nat Rev Immunol | 2010 | https://conductscience.org/library/papers/20818413 | PubMed |
| 19628705 | Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. | Blood | 2009 | https://conductscience.org/library/papers/19628705 | PubMed |
| 17609265 | Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. | J Virol | 2007 | https://conductscience.org/library/papers/17609265 | PubMed |
| 17516061 | Expression of murine killer immunoglobulin-like receptor KIRL1 on CD1d-independent NK1.1(+) T cells. | Immunogenetics | 2007 | https://conductscience.org/library/papers/17516061 | PubMed |
| 17360463 | Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17360463 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9637488
GET https://conductscience.org/api/papers/v1/9637488/cited_by?page=2